Add BrightSurf on Google Email

Science News Archive February 2025 - Page 21


Page 21 of 44

New study suggests panitumumab with low-dose capecitabine as a safer, effective maintenance treatment for advanced colorectal cancer

Researchers found that a combination of Panitumumab and low-dose Capecitabine is an effective and well-tolerated maintenance regimen for patients with wild-type KRAS metastatic colorectal cancer. The treatment delayed disease progression while managing side effects, improving patients' quality of life.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateFeb 18, 2025

Machine learning drives "autonomous" control of particle accelerators

Researchers are using machine learning to enable autonomous control of particle accelerators, opening up new possibilities for commissioning and operating high-power accelerators. The technology has been successfully applied to the CAFe2 superconducting segment, achieving global trajectory adaptive control.

SourceScience China Press·JournalScience China Physics Mechanics and Astronomy·TypeExperimental study·DateFeb 18, 2025

Biologists transform gut bacteria into tiny protein pharmacies

Researchers at Virginia Tech have developed a method to convert gut bacteria into mini protein factories that produce and release sustained flows of targeted proteins within the lower intestine. This approach eliminates a major roadblock in delivering drugs to this part of the body, offering potential treatment for chronic diseases.

SourceVirginia Tech·JournalNature·DateFeb 18, 2025

Newfound circuit better explains how the brain recognizes what is familiar and important

Researchers at NYU Langone Health identified a new direct feedback loop in the brain that mixes sensory information, memories, and emotions to label sights and sounds as more important. This discovery may lead to new solutions for problems like post-traumatic stress disorder and autism.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalNature Neuroscience·TypeExperimental study·DateFeb 18, 2025

What makes us remember our dreams?

A study published in Communications Psychology found that dream recall is influenced by individual characteristics and external factors, including positive attitude toward dreams, mind-wandering tendency, and sleep patterns. Younger participants showed higher rates of dream recall, while older individuals experienced 'white dreams.'

SourceIMT School for Advanced Studies Lucca·JournalCommunications Psychology·TypeExperimental study·DateFeb 18, 2025

Legionnaires’ disease from a lake swim

Swimming in lakes with still water can lead to infection with Legionella bacteria, causing pneumonia. Risk factors include age over 50, smoking history, and compromised immune systems. Clinicians should suspect legionnaires' disease in patients with severe pneumonia and recent travel history.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeCase study·DateFeb 18, 2025

New laparoscopic imaging technique accurately maps biological tissue for minimally invasive surgery

A new laparoscopic imaging technique uses stereo depth estimation and speckle-illumination SFDI to accurately map the optical properties of biological tissue. The device provides detailed optical property maps, enabling surgeons to identify critical tumor margins and improve clinical outcomes.

SourceSPIE--International Society for Optics and Photonics·JournalJournal of Biomedical Optics·DateFeb 17, 2025

New discovery could help protect against influenza

A preclinical trial has uncovered how beta-glucan can 'reprogram' immune cells to prevent lung inflammation and reduce the risk of illness and death from influenza. The study's findings highlight beta-glucan as a promising therapy for influenza and other emerging viral pathogens.

SourceMcGill University·JournalNature Immunology·TypeExperimental study·DateFeb 17, 2025

First insights into genotype and phenotype of familial amyotrophic lateral sclerosis in Egypt: early onset and high consanguinity

This Egyptian study sheds light on the genotype and phenotype of familial ALS, highlighting early onset, high consanguinity rates, and genetic variations. The findings suggest distinct characteristics compared to European populations, emphasizing the importance of studying ALS genetics across diverse populations.

SourceHigher Education Press·JournalFrontiers of Medicine·TypeExperimental study·DateFeb 17, 2025

Long-term decline in downward surface solar radiation

A recent study reveals a significant long-term decline in downward surface solar radiation globally, with significant decadal variations observed over land. The research highlights the role of water vapor in DSSR changes, which was previously overlooked, and shows that future DSSR changes will depend heavily on emission scenarios.

SourceScience China Press·JournalNational Science Review·DateFeb 17, 2025

Scientists at The Wistar Institute’s HIV Cure and Viral Diseases Center develop new natural killer cell strategy to target HIV

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have identified a new approach using natural killer cells to target and kill HIV-positive cells. CD64 expression enhances binding activity for holding onto antigen-specific antibodies, allowing for specific targeting and killing of infected cells.

SourceThe Wistar Institute·JournalJournal of Immunology·TypeExperimental study·DateFeb 17, 2025

Leafbot: A soft robot conquers challenging terrains

Researchers at Japan Advanced Institute of Science and Technology developed Leafbot, a soft robot that uses vibration-driven locomotion to traverse uneven surfaces. The robot's compliant structure and simple motion strategy enable it to overcome complex obstacles, making it valuable for applications such as inspection and exploration.

SourceJapan Advanced Institute of Science and Technology·JournalIEEE Transactions on Robotics·DateFeb 17, 2025

NUS Medicine pioneers ground-breaking technique to deliver drugs directly to the brain

Scientists at NUS Medicine have developed a novel approach using nasal bacteria to deliver therapeutic molecules directly to the brain, reducing appetite and improving glucose metabolism in preclinical studies. The engineered bacteria leverage the olfactory mucosa's unique properties to deliver medication with enhanced bioavailability.

Moffitt study identifies immune response that may stop breast cancer from spreading

Researchers at H. Lee Moffitt Cancer Center & Research Institute have identified a specific immune response that can prevent the spread of breast cancer cells within the body. Activating certain immune cells can stop dormant cancer cells from growing into new tumors, potentially leading to long-term survival.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalCancer Immunology Research·TypeExperimental study·DateFeb 17, 2025

‘Hey Siri, choose my medical expert.’

A new study from the University of South Australia found that most people trust AI in situations where the stakes are low, such as music suggestions. However, those with poor statistical literacy or little familiarity with AI were just as likely to trust algorithms for trivial choices as they were for critical decisions. The study also...

SourceUniversity of South Australia·JournalFrontiers in Artificial Intelligence·TypeCase study·DateFeb 17, 2025

Common drug shows promise against rare type of heart disease

A team of researchers from the University of Arizona College of Medicine – Tucson found that an FDA-approved osteoporosis treatment, risedronate, can correct a gene mutation and normalize heart function in animal models. The study provides hope for treating other rare diseases using precision treatments tailored to individual mutations.

SourceUniversity of Arizona Health Sciences·JournalJournal of Clinical Investigation·TypeExperimental study·DateFeb 17, 2025

Danish research reveals novel biomarker for autoimmune diseases

Researchers from Aarhus University have developed a method to track disease progression in patients with autoimmune diseases. The new method identifies large immuno-active complexes and can be measured in parallel, increasing capacity and reducing the need for training new staff or investing in equipment.

SourceAarhus University·JournalJournal of Translational Autoimmunity·TypeExperimental study·DateFeb 17, 2025